CN108567929A - A kind of drug of effective treatment gout - Google Patents
A kind of drug of effective treatment gout Download PDFInfo
- Publication number
- CN108567929A CN108567929A CN201810575443.1A CN201810575443A CN108567929A CN 108567929 A CN108567929 A CN 108567929A CN 201810575443 A CN201810575443 A CN 201810575443A CN 108567929 A CN108567929 A CN 108567929A
- Authority
- CN
- China
- Prior art keywords
- parts
- drug
- effective treatment
- rhizoma
- treatment gout
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
The present invention discloses a kind of drug of effective treatment gout, made of the component containing following parts by weight:10 30 parts of smilax, 20 60 parts of the root of Chinese clematis, 10 20 parts of desmodium, 10 25 parts of rhizoma atractylodis, 10 40 parts of fevervine, 10 30 parts of honeycomb, 5 20 parts of vomiting nut, 15 35 parts of HERBA EPIMEDII, 10 20 parts of scorpio, windproof 12 30 parts, 10 25 parts of corn stigma, 15 35 parts of coix seed, 10 20 parts of safflower, 5 15 parts of Rhizoma Et Radix Notopterygii, 12 30 parts of hoveniae semoveniae semen.The present invention is for being effectively improved and treating the chronic diseases such as the metabolics such as gout arthritis and rheumatic, rheumatoid arthritis.
Description
Technical field
The present invention relates to a kind of drugs of effective treatment gout.
Background technology
Broadly thinking every causes Bones and joints, the disease of myalgia that can all be attributed to rheumatism.Continuity is got off, so far
In rheumatism classification, broad sense has more than 100 kinds of disease, includes infectivity, immunity, metabolic, incretion, heredity
Disease caused by many reasons such as property, degeneration, tumprigenicity, region, Poisoning.It should be only limitted to internal medicine in the narrow sense and be immunized
Tens kinds of diseases of related scope.Some of which is sick or interdisciplinary, such as gout, osteoarthrosis, infectional arthritis etc..
Rheumatism is one group of infringement joint, bone, muscle, blood vessel and in relation to the disease based on soft tissue or connective tissue, wherein most
For autoimmune disease.Morbidity is much more hidden and slow, and the course of disease is longer, and has genetic predisposition mostly.State of an illness Chang Fanfu hairs
Make, does not recover for a long time, acquire a certain degree of difficulty in treatment.With the improvement of the quality of life, the number of patient with gout and incidence have by
Cumulative high trend.Based on Western medicine, these Western medicine have that price is high, side effect is big etc. lacks the drug of present market treatment gout
Point, index are not effected a permanent cure, and need to take for a long time, and one, which is discontinued, is then easy recurrence, and therapeutic effect is unsatisfactory.
Invention content
The purpose of the present invention is to solve defects existing in the prior art, provide a kind of medicine of effective treatment gout
Object.
In order to achieve the above objectives, solution of the invention:
A kind of drug of effective treatment gout, made of the component containing following parts by weight:10-30 parts of smilax,
20-60 parts of the root of Chinese clematis, 10-20 parts of desmodium, 10-25 parts of rhizoma atractylodis, 10-40 parts of fevervine, 10-30 parts of honeycomb, vomiting nut 5-20
Part, 15-35 parts of HERBA EPIMEDII, 10-20 parts of scorpio is 12-30 parts windproof, 10-25 parts of corn stigma, 15-35 parts of coix seed, safflower 10-
20 parts, 5-15 parts of Rhizoma Et Radix Notopterygii, 12-30 parts of hoveniae semoveniae semen.
Preferably, the parts by weight group of each component becomes:15 parts of smilax, 35 parts of the root of Chinese clematis, 15 parts of desmodium, rhizoma atractylodis
20 parts, 15 parts of fevervine, 20 parts of honeycomb, 10 parts of vomiting nut, 15 parts of HERBA EPIMEDII, 15 parts of scorpio, windproof 20 parts, 15 parts of corn stigma,
30 parts of coix seed, 10 parts of safflower, 5 parts of Rhizoma Et Radix Notopterygii, 25 parts of hoveniae semoveniae semen.
Powder, capsule or granule can be made in the drug.
After adopting the above scheme, the present invention can adjust rapidly nerve and endocrine function, and immune function and diseases prevention is made to control
The enhancing of sick ability, for the disease caused by the metabolics such as gout arthritis and rheumatic, rheumatoid arthritis have prevention and
The effect for the treatment of.
Specific implementation mode
The drug for a kind of effective treatment gout that the present invention discloses, made of the component containing following parts by weight:Soil
10-30 parts of Poria cocos, 20-60 parts of the root of Chinese clematis, 10-20 parts of desmodium, 10-25 parts of rhizoma atractylodis, 10-40 parts of fevervine, honeycomb 10-30
Part, 5-20 parts of vomiting nut, 15-35 parts of HERBA EPIMEDII, 10-20 parts of scorpio is 12-30 parts windproof, 10-25 parts of corn stigma, coix seed 15-
35 parts, 10-20 parts of safflower, 5-15 parts of Rhizoma Et Radix Notopterygii, 12-30 parts of hoveniae semoveniae semen.
Preferably, the parts by weight group of each component becomes:15 parts of smilax, 35 parts of the root of Chinese clematis, 15 parts of desmodium, rhizoma atractylodis
20 parts, 15 parts of fevervine, 20 parts of honeycomb, 10 parts of vomiting nut, 15 parts of HERBA EPIMEDII, 15 parts of scorpio, windproof 20 parts, 15 parts of corn stigma,
30 parts of coix seed, 10 parts of safflower, 5 parts of Rhizoma Et Radix Notopterygii, 25 parts of hoveniae semoveniae semen.
Powder, capsule or granule can be made in the drug.
After adopting the above scheme, the present invention can adjust rapidly nerve and endocrine function, and immune function and diseases prevention is made to control
The enhancing of sick ability, for the disease caused by the metabolics such as gout arthritis and rheumatic, rheumatoid arthritis have prevention and
The effect for the treatment of.
The product form and style of above-described embodiment and the non-limiting present invention, the ordinary skill people of any technical field
The appropriate changes or modifications that member does it all should be regarded as the patent category for not departing from the present invention.
Claims (3)
1. a kind of drug of effective treatment gout, which is characterized in that made of the component containing following parts by weight:Smilax
10-30 parts, 20-60 parts of the root of Chinese clematis, 10-20 parts of desmodium, 10-25 parts of rhizoma atractylodis, 10-40 parts of fevervine, 10-30 parts of honeycomb, horse
5-20 parts of money, 15-35 parts of HERBA EPIMEDII, 10-20 parts of scorpio is 12-30 parts windproof, 10-25 parts of corn stigma, 15-35 parts of coix seed,
10-20 parts of safflower, 5-15 parts of Rhizoma Et Radix Notopterygii, 12-30 parts of hoveniae semoveniae semen.
2. a kind of drug of effective treatment gout according to claim 1, it is characterised in that:The parts by weight of its each component
Group becomes:15 parts of smilax, 35 parts of the root of Chinese clematis, 15 parts of desmodium, 20 parts of rhizoma atractylodis, 15 parts of fevervine, 20 parts of honeycomb, vomiting nut 10
Part, 15 parts of HERBA EPIMEDII, 15 parts of scorpio, windproof 20 parts, 15 parts of corn stigma, 30 parts of coix seed, 10 parts of safflower, 5 parts of Rhizoma Et Radix Notopterygii, hoveniae semoveniae semen
25 parts.
3. a kind of drug of effective treatment gout according to claim 1, it is characterised in that:The drug can be made
Powder, capsule or granule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810575443.1A CN108567929A (en) | 2018-06-06 | 2018-06-06 | A kind of drug of effective treatment gout |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810575443.1A CN108567929A (en) | 2018-06-06 | 2018-06-06 | A kind of drug of effective treatment gout |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108567929A true CN108567929A (en) | 2018-09-25 |
Family
ID=63573371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810575443.1A Withdrawn CN108567929A (en) | 2018-06-06 | 2018-06-06 | A kind of drug of effective treatment gout |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108567929A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104352901A (en) * | 2014-10-09 | 2015-02-18 | 姜成玲 | Traditional Chinese medicine for treating gout |
US20180028589A1 (en) * | 2016-07-29 | 2018-02-01 | Carolyn Wallace | Pain Relief Composition |
CN107648509A (en) * | 2016-07-26 | 2018-02-02 | 南京广阔天地生物科技有限公司 | A kind of formula for treating gout |
-
2018
- 2018-06-06 CN CN201810575443.1A patent/CN108567929A/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104352901A (en) * | 2014-10-09 | 2015-02-18 | 姜成玲 | Traditional Chinese medicine for treating gout |
CN107648509A (en) * | 2016-07-26 | 2018-02-02 | 南京广阔天地生物科技有限公司 | A kind of formula for treating gout |
US20180028589A1 (en) * | 2016-07-29 | 2018-02-01 | Carolyn Wallace | Pain Relief Composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1117391A (en) | Medicine for treating rheumatic disease | |
Sanders et al. | The use of glucosamine, devil's claw (Harpagophytum procumbens), and acupuncture as complementary and alternative treatments for osteoarthritis | |
CN104998202B (en) | A kind of Chinese medicine for treating cervical spondylosis | |
CN108524819A (en) | A kind of drug of effective treatment gout | |
CN108567929A (en) | A kind of drug of effective treatment gout | |
CN108159125A (en) | A kind of external medicine composition and its preparation method and application of expelling wind and clearing away cold, promoting blood circulation and stopping pain | |
CN103142766B (en) | Medicine for controlling coccidiosis in rabbits | |
CN108653626A (en) | A kind of formula for treating gout | |
CN104758451A (en) | Traditional Chinese medicine composite for treating gout | |
CN101406631B (en) | Medicament for treating hyperkinetic symptom of children | |
CN108126024A (en) | A kind of pharmaceutical composition for treating rheumatoid arthritis | |
CN1190215C (en) | Chinese medicine for treating rheumatism | |
CN101537090B (en) | Pharmaceutical composition for treating lumbar intervertebral disc protrusion, preparation method and use thereof | |
CN105614227A (en) | High blood pressure treating health rice powder | |
CN109985204A (en) | A kind of the multitude's effective prescription and application method of rheumatoid arthritis | |
CN105560556A (en) | Tenosynovitis treating drug and preparation method thereof | |
CN105770013A (en) | Traditional Chinese medicine for treating temporomandibular joint disorder and preparation method of traditional Chinese medicine | |
CN105663826A (en) | Traditional Chinese medicine composition for treating gout | |
MS et al. | CONCEPT OF DESIGNING AN AYURVEDIC AUSHADHA YOGA (MEDICINAL FORMULATION) IN CLINICAL PERVIEW | |
Amritha et al. | YUKTI IN DESIGNING AN AYURVEDIC AUSHADHA YOGA (MEDICINAL FORMULATION) IN CLINICAL PURVIEW | |
Künnemann | Herbal remedies as a potential alternative therapy for arthritis | |
Sadegh et al. | Effect of Saffron Oral Capsules on Anxiety Level of Patients with Diabetes Mellitus. | |
CN105194352A (en) | Traditional Chinese medicine composition capable of improving learning and memory abilities and preparation method thereof | |
Vekariya et al. | Evaluation of acute toxicity and intestinal transit time of Croton tiglium L. seeds | |
CN105147969A (en) | Traditional Chinese medicine for treating arthralgia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180925 |